Perspective Therapeutics to Participate in Upcoming Investor Conferences in December

Rhea-AI Summary

Perspective Therapeutics (NYSE AMERICAN: CATX), a radiopharmaceutical company focused on cancer treatments, has announced its participation in two major investor conferences in December 2024. The company's senior leadership will be available for one-on-one meetings with investors at both events.

The first appearance will be at the 36th Annual Piper Healthcare Conference in New York on December 3, featuring a fireside chat from 10:00-10:25 AM ET. The second event is the 7th Annual Evercore HealthCONx in Coral Gables, FL on December 5, with a fireside chat scheduled for 10:50-11:10 AM ET. Both events will be webcasted and available for replay for 90 days through the company's investor website.

SEATTLE, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the following upcoming investor conferences.

36^th Annual Piper Healthcare Conference
Date: December 3, 2024
Location: New York, NY
Format: Fireside Chat
Time: 10:00-10:25 AM ET

7th Annual Evercore HealthCONx
Date: December 5, 2024
Location: Coral Gables, FL
Format: Fireside Chat
Time: 10:50-11:10 AM ET

Webcast events can be accessed live, and replays will be archived for 90 days and available through the Investors page on the Perspective website at https://perspectivetherapeutics.com/investor-center. 

About Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc., is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has proprietary technology that utilizes the alpha emitting isotope ²¹²Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides. The Company is also developing complementary imaging diagnostics that incorporate the same targeting peptides which provide the opportunity to personalize treatment and optimize patient outcomes. This "theranostic" approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity.

The Company's melanoma (VMT01) and neuroendocrine tumor (VMT-α-NET) programs have entered Phase 1/2a imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at several leading academic institutions. The Company has also developed a proprietary ²¹²Pb generator to secure key isotopes for clinical trial and commercial operations.

For more information, please visit the Company's website at www.perspectivetherapeutics.com.

FAQ

When is Perspective Therapeutics (CATX) presenting at the Piper Healthcare Conference?

Perspective Therapeutics (CATX) will present at the 36th Annual Piper Healthcare Conference on December 3, 2024, from 10:00-10:25 AM ET in New York, NY.

Where can I watch Perspective Therapeutics (CATX) investor conference webcasts?

The webcasts can be accessed through Perspective Therapeutics' investor website at perspectivetherapeutics.com/investor-center, where replays will be available for 90 days.

What type of meetings will Perspective Therapeutics (CATX) offer at the December 2024 conferences?

Perspective Therapeutics will offer one-on-one meetings with investors at both conferences, along with fireside chat presentations.

When is Perspective Therapeutics (CATX) presenting at the Evercore HealthCONx conference?

Perspective Therapeutics will present at the 7th Annual Evercore HealthCONx conference on December 5, 2024, from 10:50-11:10 AM ET in Coral Gables, FL.